Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Diaceutics (DXRX)

Price 103.50p on 19-04-2024 at 09:50:02
Change 0.50p 0.49%
Buy 104.00p
Sell 103.00p
Buy / Sell DXRX Shares
Last Trade: Buy 1,800.00 at 103.6499p
Day's Volume: 19,733
Last Close: 103.00p
Open: 103.50p
ISIN: GB00BJQTGV64
Day's Range 103.50p - 103.50p
52wk Range: 80.50p - 109.00p
Market Capitalisation: £88m
VWAP: 103.14036p
Shares in Issue: 85m

Recent Trades History Diaceutics (DXRX)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 1,800 103.6499p Ordinary
07:37:13 - 19-Apr-24
Sell* 8,000 103.20p Ordinary
07:09:48 - 19-Apr-24
Sell* 8,000 103.00p Ordinary
07:09:34 - 19-Apr-24
Sell* 1,932 103.00p Ordinary
07:02:59 - 19-Apr-24
Sell* 1 103.00p SI Trade
07:00:54 - 19-Apr-24

Share Price History for Diaceutics

Time period:
to
Date Open High Low Close Volume

Share News for Diaceutics

TRADING UPDATES: Roadside shares suspended; Adnams looks for funds

2nd Apr 2024 19:02

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

Diaceutics upgrades diagnositc commercialisation platform, DXRX

21st Mar 2024 13:58

(Alliance News) - Diaceutics PLC on Thursday said it has launched a "significant upgrade" to its DXRX platform. Read More

TRADING UPDATES: Sondrel wins USD23 million contract

27th Feb 2024 14:18

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Diaceutics announces new marketing partnership with KPMG

14th Feb 2024 13:52

Diaceutics PLC - Belfast-based provider of diagnostic commercialisation services to pharmaceutical and biotechnology companies - Announces strategic alliance with KPMG LLC, which provides tax, audit and advisory services and commercialisation solutions for life sciences and healthcare companies. Diaceutics says the partnership will facilitate joint marketing of commercialisation solutions to life science customers for commercialisation of precision medicines. Read More

Diaceutics maintains "momentum" for year ahead on revenue rise in 2023

30th Jan 2024 11:16

(Alliance News) - Diaceutics PLC on Tuesday highlighted the extent of market opportunities for its product, after seeing annual revenue rise despite tough macroeconomic conditions. Read More

FTSE 100 Latest
Value7,839.51
Change-37.54

Login to your account

Forgot Password?

Not Registered